Central Florida Pulmonary Group is a clinical research site located in Orlando, Florida, United States 32803.
Crixeo Clinical Trials Trust Score: 24/100 (FAILING). This profile has not yet been claimed by the site owner.
Central Florida Pulmonary Group has participated in 31 clinical trials with 6 currently active.
Therapeutic areas: Pulmonary Arterial Hypertension, Systemic Sclerosis With and Without Interstitial Lung Disease, PAH.
Sponsors: Actelion, Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, United Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Florida · View every site in Orlando
Trust Score: 24/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Central Florida Pulmonary Group has a Crixeo Trust Score of 24/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Central Florida Pulmonary Group has 31 clinical trials on record, with 6 currently active. Their work covers Pulmonary Arterial Hypertension, Systemic Sclerosis With and Without Interstitial Lung Disease, PAH.
Central Florida Pulmonary Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.